European Market Report for Cardiac Output Monitoring 2016 - MedCore
The total cardiac output market will continue to see strong growth over the forecast period due to increased awareness of the efficacy of CO monitoring. This measurement has become an integral part of critical care practice and may help in facilitating improved patient outcomes. Operating rooms (ORs) have traditionally been the primary users of cardiac output monitoring and pulmonary artery catheters (PACs). Newer therapies, however, are geared toward quickly identifying patient conditions on the front line, namely within intensive care units (ICUs) and emergency rooms (ERs), where CO may be utilized as an early warning indicator for circulatory disturbances.
With ongoing improvements in reading accuracy, it is expected that the non-invasive and minimally invasive technologies will drive growth in the ICU and ER market and take market share from PAC procedures in the OR. Over the forecast period the minimal and non-invasive monitoring segments will continue to grow, motivated in part by demand-driven product advancements. Modern non-invasive technologies are greatly improved and have become more widely accepted as an alternative to invasive CO monitoring in some settings. This trend is exemplified through the increased adoption of Bioreactance® and non-invasive pulse pressure based CO monitoring devices and methodologies. While the industry’s direction may be detrimental to the health of the invasive monitoring segment, there is some degree of insulation against cannibalization due to the acceptance of PAC procedures as the most precise form of CO monitoring. The market split will stabilize towards the end of the forecast period, with the non-invasive segment lagging behind the minimally invasive segment across Europe, due to fragmented uptake of the newer technologies.
Cardiac output (CO) refers to the volume of blood being pumped by the heart. Monitoring of patient cardiac output is rapidly becoming a standard of care and a vital part of early diagnosis and treatment. It is also important in the management of heart attacks and for monitoring of sepsis patients. The inclusion of cardiac output monitoring in treatments provides valuable information on the volume tissue perfusion and oxygen delivery. Low-cardiac output indicates that there is insufficient circulation and potential starvation of vital internal organs. In instances of low cardiac output, circulation will be diverted from the gut in order to supply the heart, brain and skeletal muscles with oxygen. Insufficient volumes of oxygen and glucose to cells can cause irreversible damage and result in deterioration of the patients’ condition, possibly leading to death.